Read this company snapshot
Daily valuation snapshot
Amarin Corp Plc: source evidence dated 2026-10-09.
- Daily close (USD)
- $12.03
- Market capitalization (USD)
- $266,518,180.87
- Price / earnings (TTM)
- Not reported
- Price / book
- 0.6
The source values and product destination above identify the example to inspect.
What business is this, and what does its dated valuation mean?
Check the market day first. P/E uses trailing earnings; book value and market capitalization answer different questions.
Daily valuation dataset and column definitionsOpen the company research view or ask Aurora to reconcile reporting periods, earnings, debt and the figures behind the valuation.
Research AMRN in the app
Open the company research view or ask Aurora to reconcile reporting periods, earnings, debt and the figures behind the valuation.
Research AMRN in the appKeep reporting dates and units beside the answer, and inspect its original citations.
Company overview
Amarin Corporation plc, a pharmaceutical company, engages in the commercialization and development of therapeutics for the treatment of cardiovascular diseases in the United States, Europe, and internationally. The company offers VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. It sells its products principally through wholesalers, selected regional wholesalers, and specialty pharmacy providers. The company has a collaboration with Mochida Pharmaceutical Co., Ltd. to develop and commercialize drug products and indications based on the active pharmaceutical ingredient in Vascepa, the omega-3 acid, EPA. The company was formerly known as Ethical Holdings plc and changed its name to Amarin Corporation plc in 1999. Amarin Corporation plc was incorporated in 1989 and is headquartered in Dublin 2, Ireland.
Daily valuation snapshot
See the complete daily valuation snapshot
These values come from the daily market snapshot dated 2026-10-09. TTM means trailing twelve months. Use the market date when comparing AMRN with another company.
Scroll sideways to compare all columns. Select a heading to sort.
| Daily close (USD) | $12.03 |
| Market capitalization (USD) | $266,518,180.87 |
| Price / earnings (TTM) | Not reported |
| Price / book | 0.6 |
No matching rows. Clear the filter to see all records.
Read AMRN's valuation metrics
Company size
Amarin Corp Plc's recorded market capitalization is $266,518,180.87. It measures the market value of the company's equity, rather than its revenue or cash balance.
Price relative to earnings
P/E compares share price with trailing annual earnings per share. For a company with losses, inspect the earnings figures directly rather than treating a negative multiple as a cheap valuation.
Price relative to book equity
AMRN's recorded price-to-book ratio is 0.6. That compares its market equity value with recorded book equity. Examine its business and balance sheet to understand why those values differ.
Research Amarin Corp Plc with Aurora
Use the snapshot above to ask a specific question about AMRN. Ask for the report period and the figures behind the explanation, then compare the answer with the company's business description.
Continue the research
Follow AMRN's ownership disclosures to see who filed a transaction or position and when it became public. To turn a research idea into a strategy, define an entry rule and test its dated observations.